tiprankstipranks
Trending News
More News >
Biostar Pharmaceuticals (BSPM)
OTHER OTC:BSPM
US Market
Advertisement

Biostar Pharmaceuticals (BSPM) Income Statement

Compare
54 Followers

Biostar Pharmaceuticals Income Statement

Last quarter (Q3 2017), Biostar Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Biostar Pharmaceuticals's net income was $-654.86K. See Biostar Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 16
Total Revenue
$ 2.38M
Gross Profit
$ 915.17K
Operating Expenses
$ 4.48M
Depreciation and Amortization
$ 1.14M
EBITDA
$ -1.70M
Operating Income
$ -3.56M
Other Income/Expenses
$ 518.93K
Pretax Income
$ -3.05M
Net Income
$ -5.70M
Per Share Metrics
Basic EPS
$ -2.48
Diluted EPS
$ -2.48
Weighted Average Shares Outstanding
2.30M
Weighted Average Shares Outstanding (Diluted)
2.30M
Currency in USD

Biostar Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis